My research is dedicated to developing new drugs and therapies for retinal vascular diseases and expanding the understanding of them. The ever-evolving challenges of research fuel my curiosity and bring a deep sense of accomplishment. I aim to integrate emerging technologies like AI and gene therapy to revolutionize diagnostics and treatment protocols. I am also committed to contributing to a dynamic, collaborative scientific community focused on mitigating the impact of retinal diseases worldwide. Valuing the research opportunity provided by Keio University, I am resolved to persistently apply my efforts toward these endeavors.

I am investigating the relationship between ocular conditions such as presbyopia, myopia, and dry eye and quality of life, including the interrelationship with other systemic conditions. I am also exploring animal models of diabetic retinopathy to better understand the disease pathogenesis and develop new treatments in humans. I have a Doctorate of Optometry and a Master’s in Public Health, so I am experienced in clinical practice and understand that side of the field. In the future, I hope to find positions that allow me to continue to research ocular conditions and improve patient outcomes.

ヒトiPS細胞から脳オルガノイドを作製する技術を身につけ、脳オルガノイドをマウス脳に移植する方法を確立した。現在、様々な脳オルガノイドモデルを創出することが可能になってきており、マウス脳への移植技術と組み合わせるとあらゆる疾患モデルを創出することができると考えている。神経変性疾患の原因究明や治療法の確立に向け、ヒトの病態に限りなく近いモデルを作製し、自分の研究成果を社会に還元していきたい。